Gemcitabine Kabi

Gemcitabine Hydrochloride is a chemotherapy drug used to treat various cancers. It works by slowing or stopping cancer cell growth, often administered intravenously.

Gemcitabine Hydrochloride is primarily used in cancer treatment. It is often prescribed for cancers of the pancreas, lung, breast, and ovary. The drug works by interfering with the growth and spread of cancer cells. Patients typically receive this medication as part of a broader treatment plan.

Common effects of Gemcitabine Hydrochloride may include nausea, vomiting, fatigue, and a higher risk of infections. Some patients may experience hair loss or changes in blood cell counts. These effects can vary widely depending on the individual and the specific treatment plan.

Gemcitabine Hydrochloride should be handled with care, as it is a potent chemotherapy agent. It is important to follow the healthcare provider's instructions closely. Patients should be monitored regularly for side effects and any signs of infection. Proper storage and disposal are crucial to ensure safety.

Gemcitabine Hydrochloride may interact with other medications, including certain antibiotics and vaccines. It is important to inform healthcare providers about all medications being taken. Alcohol and other substances that suppress the immune system should be avoided during treatment.